<DOC>
	<DOCNO>NCT02923830</DOCNO>
	<brief_summary>The purpose study determine safe effective flush solution maintain patency ( unobstructed flow ) BioFlo implant port catheter . The complication rate patient whose port flush saline compare complication rate patient whose port flush combination saline heparinized saline .</brief_summary>
	<brief_title>Maintaining Patency BioFlo Implanted Port Catheters With Saline Only Flushes</brief_title>
	<detailed_description>The purpose study determine safe effective flush solution maintain patency ( unobstructed flow ) BioFlo implant port catheter . The complication rate patient whose port flush saline compare complication rate patient whose port flush combination saline heparinized saline . These complication include partial complete obstruction , infection central line , and/or onset heparin induce thrombocytopenia .</detailed_description>
	<criteria>Able read understand English Has BioFlo implant port place le one ( 1 ) year Evidence patent BioFlo port catheter prior enrollment study Is receive active treatment ( i.e. , receive therapeutic drug ) BioFlo implant port Current treatment protocol project continue minimum three ( 3 ) month Anticipates receive care identify center 12 month follow enrollment study Does receive care BioFlo implant port facility Has document heparin platelet antibody ( i.e. , could randomize either group ) allergy heparin Receiving therapeutic dose anticoagulant ( e.g. , warfarin , heparin , enoxaparin ) Does meet one inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>